Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
SUNDRUG, First Half Ordinary Profit Increases by 10%, Jul-Sep Ordinary Profit Increases by 6%
Consolidated Financial Results for the Six Months Ended September 30, 2025[Japanese GAAP]
Consolidated Financial Results for the Six Months Ended September 30, 2025[Japanese GAAP]
Consolidated Financial Results for the Six Months Ended September 30, 2025[Japanese GAAP]
Notice Regarding Revision of Non-consolidated Financial Results Forecasts for the Six Months Ending September 30, 2025 and the Fiscal Year Ending Marc
SUNDRUG, Apr-Jun (1Q) Ordinary Profit Increases by 14%
Consolidated Financial Results for the Three Months Ended June 30, 2025[Japanese GAAP]
Notice Regarding Receipt of Dividends from Consolidated Subsidiaries
Notice Regarding Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation
Notice Regarding Disposal of Treasury Shares as Restricted Stock Compensation
SUNDRUG, 5% Increase in Ordinary Profit, Update Record High for Third Consecutive Term, Dividend Raised by 1 yen
Consolidated Financial Results for the Fiscal Year Ended March 31, 2025 [Japanese GAAP]
SUNDRUG, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 2%
Notice Regarding the Absorption-type Merger of a Wholly owned Subsidiary (Simplified Merger)
SUNDRUG CO.,LTD., First Half Ordinary Profit Revised Downward to an Unexpected 1%Decrease